Ani pharmaceuticals announces the launch of levofloxacin oral solution, usp

Baudette, minn., march 27, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced the launch of levofloxacin oral solution, a generic version of the reference listed drug (rld) levaquin®. the current annual u.s. market for levofloxacin oral solution is approximately $7.1 million, according to latest estimates from iqvia/ims health, a leading healthcare data and analytics provider.
ANIP Ratings Summary
ANIP Quant Ranking